The TSXV serves as a vital platform for early-stage, high-growth companies, providing access to capital and a strong investor network. In 2024, 80% of the TSXV Venture 50™ companies operated ...

The U.S. stands at a crossroads in light of rising drug prices and it is unclear what the future will hold in answer to the ...

BioLogic Pharma Solutions aims to be the trusted partner for companies handling complex drug development and commercialization pathways.

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...